Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 3.25
(0.31%)
CNY 3.25
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.03 Billion | 12.31 Billion | 21.05 Billion | 27.2 Billion | 35.25 Billion | 33.91 Billion |
| Cost of Revenue | 7.21 Billion | 10.63 Billion | 17.22 Billion | 22.22 Billion | 28.43 Billion | 27.42 Billion |
| Gross Profit | 822.06 Million | 1.67 Billion | 3.83 Billion | 4.97 Billion | 6.81 Billion | 6.49 Billion |
| Operating Expenses | 948.69 Million | 1.6 Billion | 2.8 Billion | 3.38 Billion | 4.22 Billion | 3.65 Billion |
| Selling, General and Administrative Expenses | 602.63 Million | 1.15 Billion | 2.17 Billion | 2.7 Billion | 3.31 Billion | 2.86 Billion |
| Research and Development Expenses | 39.54 Million | 22.67 Million | 11.56 Million | 8.91 Million | 6.97 Million | - |
| Other Expenses | 63.15 Million | 430.44 Million | 621.5 Million | 662.24 Million | 904.92 Million | 780.73 Million |
| Cost and Expenses | 8.16 Billion | 12.24 Billion | 20.02 Billion | 25.6 Billion | 32.66 Billion | 31.07 Billion |
| Operating Income | -126.63 Million | 67.11 Million | 1.3 Billion | 1.7 Billion | 2.53 Billion | 2.7 Billion |
| Interest Expense | 303.7 Million | 407.7 Million | 554.41 Million | 590.11 Million | 737.11 Million | 576.24 Million |
| Income Tax Expense | -167.38 Million | -4.43 Million | 83 Million | 290.92 Million | 537.35 Million | 684.82 Million |
| Earnings before Tax | -135.41 Million | -1.74 Billion | 465.01 Million | 915.47 Million | 102.37 Million | 1.96 Billion |
| Net Income | 20.31 Million | -1.73 Billion | 382.01 Million | 624.55 Million | -434.97 Million | 1.27 Billion |
| Earnings Per Share Basic | 0.01 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 |
| Earnings Per Share Diluted | 0.01 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.47 Billion | 1.47 Billion | 1.47 Billion | 1.49 Billion | 1.48 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.47 Billion | 1.47 Billion | 1.47 Billion | 1.49 Billion | 1.48 Billion |
| Gross Margin | 0.10 | 0.14 | 0.18 | 0.18 | 0.19 | 0.19 |
| EBIT Margin | 0.05 | -0.04 | 0.08 | 0.07 | 0.08 | 0.09 |
| Profit Margin | 0.00 | -0.14 | 0.02 | 0.02 | -0.01 | 0.04 |
| EBITDA | 387.96 Million | -960.81 Million | 1.33 Billion | 1.79 Billion | 1.37 Billion | 2.98 Billion |
| Earnings Before Tax Margin | -0.02 | 0.01 | 0.06 | 0.06 | 0.07 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.01 Billion | 2 Billion | 2.01 Billion | 8.03 Billion | 1.92 Billion | 2.02 Billion |
| Cost of Revenue | 1.73 Billion | 1.78 Billion | 1.77 Billion | 7.2 Billion | 1.92 Billion | 1.73 Billion |
| Gross Profit | 275.1 Million | 213.46 Million | 243.13 Million | 827.03 Million | 8.59 Million | 285.27 Million |
| Operating Expenses | 228.26 Million | 197.6 Million | 191.91 Million | 891.8 Million | 135.46 Million | 255.49 Million |
| Selling, General and Administrative Expenses | 226.17 Million | 196.27 Million | 181.49 Million | - | -107.78 Million | 365.73 Million |
| Research and Development Expenses | 2.08 Million | 2.03 Million | 3.1 Million | - | 4.43 Million | 3.91 Million |
| Other Expenses | - | 708.08 Thousand | -1.97 Million | -286.2 Million | -268.35 Million | 159.26 Million |
| Cost and Expenses | 1.96 Billion | 1.98 Billion | 1.96 Billion | 8.09 Billion | 2.05 Billion | 1.99 Billion |
| Operating Income | 46.84 Million | 15.85 Million | 26.38 Million | -126.63 Million | -177.73 Million | -13.72 Million |
| Interest Expense | 58.61 Million | 41.42 Million | 67.54 Million | 303.7 Million | 55.94 Million | 80.15 Million |
| Income Tax Expense | -4.76 Million | -6.2 Million | 5.83 Million | -167.38 Million | -172.81 Million | -20.08 Million |
| Earnings before Tax | 6.92 Million | 15.77 Million | 24.41 Million | -135.41 Million | -168.67 Million | -33.84 Million |
| Net Income | 7.78 Million | 15.85 Million | 15.16 Million | 20.31 Million | 1.09 Million | -11.44 Million |
| Earnings Per Share Basic | 0.01 | 0.01 | 0.01 | - | 0.00 | -0.01 |
| Earnings Per Share Diluted | 0.01 | 0.01 | 0.01 | - | 0.00 | -0.01 |
| Weighted Average Shares Outstanding | 1.49 Billion | 1.49 Billion | 1.51 Billion | 1.5 Billion | 1.51 Billion | 1.5 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.49 Billion | 1.49 Billion | 1.51 Billion | 1.5 Billion | 1.51 Billion | 1.5 Billion |
| Gross Margin | 0.14 | 0.11 | 0.12 | 0.10 | 0.00 | 0.14 |
| EBIT Margin | 0.03 | 0.04 | 0.03 | - | -0.16 | 0.17 |
| Profit Margin | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | -0.01 |
| EBITDA | 65.54 Million | 71.52 Million | 66.13 Million | - | -313.88 Million | 336.6 Million |
| Earnings Before Tax Margin | 0.02 | 0.01 | 0.01 | -0.02 | -0.09 | -0.01 |
EESH
HQH
FCUV
HPR
2284
3IINFOLTD